BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30998541)

  • 1. Microscopic Hematuria as a Screening Tool for Urologic Malignancies in Women.
    Jeppson PC; Jakus-Waldman S; Yazdany T; Schimpf MO; Ferzandi TR; Yurteri-Kaplan LA; Knoepp L; Mamik M; Resnick HE; Ward RM;
    Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):9-15. PubMed ID: 30998541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of microscopic hematuria: a critical review and proposed algorithm.
    Niemi MA; Cohen RA
    Adv Chronic Kidney Dis; 2015 Jul; 22(4):289-96. PubMed ID: 26088073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Diagnostic Yield of Cystoscopy and Computed Tomographic Urography for Urinary Tract Cancers in Patients Evaluated for Microhematuria: A Systematic Review and Meta-analysis.
    Waisbrod S; Natsos A; Wettstein MS; Saba K; Hermanns T; Fankhauser CD; Müller A
    JAMA Netw Open; 2021 May; 4(5):e218409. PubMed ID: 33970257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in the diagnostic evaluation of microhematuriaand implications for the detection of urologic malignancy.
    Matulewicz RS; Demzik AL; DeLancey JO; Popescu O; Makarov DV; Meeks JJ
    Urol Oncol; 2019 May; 37(5):300.e1-300.e7. PubMed ID: 30661870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microhematuria in Women: Prevalence of Malignancy and Risk Score Evaluation.
    Saxon GM; Patil D; Hammett J
    Urology; 2022 Feb; 160():34-39. PubMed ID: 34788666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscopic hematuria as a screening marker for urinary tract malignancies.
    Sugimura K; Ikemoto SI; Kawashima H; Nishisaka N; Kishimoto T
    Int J Urol; 2001 Jan; 8(1):1-5. PubMed ID: 11168689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microscopic hematuria in the evaluation of urologic malignancy in renal transplant recipients.
    Kim DY; Abouljoud M; Parasuraman R
    Transplant Proc; 2010 Jun; 42(5):1641-2. PubMed ID: 20620491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the relative risk of urologic malignancy in microscopic hematuria patients after negative evaluation? A long-term population-based retrospective analysis of 8465 patients.
    Lisanti CJ; Graeber A; Syed H; Moeck A; Rittel AG; Aden JK; Schwope R; Jellison F
    Abdom Radiol (NY); 2023 Mar; 48(3):1011-1019. PubMed ID: 36592198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematuria.
    Peterson LM; Reed HS
    Prim Care; 2019 Jun; 46(2):265-273. PubMed ID: 31030828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of urologic malignancies in patients with asymptomatic dipstick hematuria: prospective study with 13 years' follow-up.
    Mishriki SF; Nabi G; Cohen NP
    Urology; 2008 Jan; 71(1):13-6. PubMed ID: 18242356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual-risk-score for urinary tract malignancy in patients with microscopic hematuria.
    Sancı A; Özkaya MF; Kubilay E; Gokce Mİ; Süer E; Gülpinar O; Baltacı S; Turkolmez K
    Int J Clin Pract; 2021 Oct; 75(10):e14662. PubMed ID: 34322953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic Microscopic Hematuria in Women.
    Female Pelvic Med Reconstr Surg; 2017; 23(4):228-231. PubMed ID: 28650895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary tract cancer screening through analysis of urinary red blood cell volume distribution.
    Wakui M; Shiigai T
    Int J Urol; 2000 Jul; 7(7):248-53. PubMed ID: 10910226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Committee Opinion No.703: Asymptomatic Microscopic Hematuria in Women.
    Obstet Gynecol; 2017 Jun; 129(6):e168-e172. PubMed ID: 28368896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Committee Opinion No. 703 Summary: Asymptomatic Microscopic Hematuria in Women.
    Obstet Gynecol; 2017 Jun; 129(6):1153-1154. PubMed ID: 28538493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microhematuria in Postmenopausal Women: Adherence to Guidelines in a Tertiary Care Setting.
    Bradley MS; Willis-Gray MG; Amundsen CL; Siddiqui NY
    J Urol; 2016 Apr; 195(4 Pt 1):937-41. PubMed ID: 26523879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Harms of Hematuria Evaluation: Modeling the Risk-Benefit of Using Split Bolus Computerized Tomography Urography to Reduce Radiation Exposure in a Theoretical Cohort.
    Dallmer JR; Robles J; Wile GE; Koyama T; Barocas DA
    J Urol; 2019 Nov; 202(5):899-904. PubMed ID: 31188730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization and Yield of CT Urography: Are the American Urological Association Guidelines for Imaging of Patients With Asymptomatic Microscopic Hematuria Being Followed?
    Skaggs AW; Loehfelm TW; Fananapazir G; Dall'Era M; Corwin MT
    AJR Am J Roentgenol; 2021 Jan; 216(1):106-110. PubMed ID: 32755213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis.
    Shinagare AB; Silverman SG; Gershanik EF; Chang SL; Khorasani R
    Am J Med; 2014 Jul; 127(7):625-32. PubMed ID: 24565590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of macroscopic haematuria in diagnosing urological cancers: a meta-analysis.
    Buntinx F; Wauters H
    Fam Pract; 1997 Feb; 14(1):63-8. PubMed ID: 9061347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.